Latest Regulatory Approval News

Nyrada reports successful completion of five cohorts in its Phase I trial of Xolatryp with no safety concerns, alongside compelling preclinical neuro- and cardioprotective data. A Phase IIa trial targeting heart attack patients is slated for early 2026.

Next Science reports a 10% decline in quarterly product sales but advances a $50 million asset sale to Demetra Holdings, signaling a pivotal shift in its business strategy.

Jupiter Mines reports record FY2025 manganese sales and production at Tshipi mine, while Q4 earnings dip due to lower prices and higher costs. Exxaro’s planned majority acquisition signals a new chapter for the asset.

Traka Resources has secured a strategic joint venture in Guinea’s Siguiri Basin while streamlining its Australian portfolio, though a legal dispute with its Guinea partner clouds the project’s future.

Lincoln Minerals has identified multiple high-priority drill targets at its Minbrie Copper-Base Metals Project with drilling planned for late 2025, while its Kookaburra Graphite Project achieves battery-grade purity, underscoring the company’s strategic positioning in critical minerals.

Frontier Energy advances its strategic investor process with multiple proposals and prepares bids for the 2025 Capacity Investment Scheme tender, while progressing key development milestones for its Waroona Renewable Energy Project.

PainChek Limited has secured a A$7.5 million placement to fuel its international expansion, with US FDA clearance for its adult pain assessment app expected imminently. The company reports strong license growth and a 26% revenue increase year-on-year.

Estrella Resources has made significant strides in its maiden manganese drilling campaign in Timor-Leste, confirming high-grade mineralisation and advancing a major limestone marketing agreement with an Indonesian partner.

Juno Minerals has agreed to sell its Mount Mason DSO Hematite Project for A$6 million cash plus a 2% royalty, while maintaining focus on its flagship Mount Ida Magnetite Project. The transaction strengthens Juno’s cash position and sets the stage for renewed development efforts.

Battery Age Minerals has initiated its maiden drilling campaign at the Bleiberg Zinc-Germanium Project following regulatory approval, while advancing exploration at El Aguila with a $3 million capital raise backing its growth.

MAC Copper Limited shareholders will vote on a court-sanctioned scheme of arrangement proposing Harmony Gold’s acquisition at a 32% premium. The transaction, valued at over $1 billion, requires shareholder and regulatory approvals before completion.

Bio-Gene Technology Limited has secured $2.45 million to fund critical safety studies and scale-up production of its novel insecticides Flavocide and Qcide, positioning the company for upcoming regulatory approvals and commercial partnerships.